A blood test based on whole-genome sequencing achieved 99% sensitivity and specificity for detecting HPV-positive head and neck cancer. Early postoperative detection of circulating tumor DNA predicted ...

The global antibody testing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% between ...

However, the test for antibodies against HPV16 E6 is not suitable for assessing the risk for cervical cancer and other HPV-associated cancers in genital areas. As opposed to cancer of the oropharynx, ...

HARLINGEN, Texas (ValleyCentral) — January is Cervical Cancer Awareness Month, and Valley doctors say prevention is key.

Regular cervical cancer screening using HPV testing and/or Pap tests can prevent up to 90% or more of cervical cancers by detecting and treating precancerous lesions early, making it one of the most ...

Pap tests and HPV testing are a vital part of women's health care, but many people dread the invasive examination every three years. For some women, particularly sexual violence survivors, getting ...

Self-collected vaginal specimens are now acceptable for cervical cancer screening for women ages 30 to 65 with an average risk of cervical cancer, according to new guidelines released Jan. 5 by the ...

LONDON (Reuters) - Antibodies to a high-risk type of a virus that causes mouth and throat cancers when transmitted via oral sex can be detected in blood tests many years before onset of the disease, ...

While these tests can act as a supplement, the pelvic exam may still be necessary in some cases. The U.S. Food and Drug Administration approved two new self-tests to detect HPV. These new tests would ...

Medicare Part B generally covers HPV tests every five years for individuals ages 30–65 without symptoms, as part of a Pap test. Individuals over 65 may not need regular HPV testing if previous results ...

Hamda Mukundwa, a 39-year-old mother of two from Kigali’s Nyamirambo suburb, first heard about Rwanda’s new self-sampling ...

Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred screening strategy” for cervical cancer starting at age 30, according to a new ...